News from Japan

2019-07-16T18:24:12+02:00April 9, 2019|Japan|

From President Beverley Yamamoto, HAE Japan (HAEJ): Icatibant has now been approved for acute attack in Japan and now for the first time patients have access to a therapy that can self-inject. It is making a big difference to patient lives already. We are still working hard to get self-administration of C1-inhibitor approved and making [...]


2019-05-12T08:43:25+02:00February 13, 2019|

HAE JAPAN 遺伝性血管性浮腫患者会NPO法人HAEジャパン(HAEJ) Japan  ·  East & Southeast Asia On this page we have pulled together presently available information relevant for HAE patients and caregivers in Japan. HAE online in Japan Visit us on Facebook [...]